Tracked for
Impact Factor
1.5
CiteScore
60 days
Time to First Decision

Gout, Urate, and Crystal Deposition Disease, Volume 3, Issue 1

2025 March - 4 articles

Cover Story: China now has the highest number of gout cases globally; its prevalence is increasing with earlier onset and rising numbers of cases among adolescents. This Review summarizes a decade of epidemiology, clinical, and research advances in China, including hyperuricemia classification-based urate-lowering therapy, urine alkalization strategies, and genetic insights into drug response. We also explore the emerging roles of metabolomics and gut microbiota in non-invasive diagnosis and precision management. View this paper

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (4)

Select all

Review

1 Citations

3,278 Views

17 Pages

Convergence of Psoriatic Arthritis and Hyperuricemia: A Review of Emerging Data from This New Concept Called “Psout”

Renaud Felten,
Laura Widawski,
Pierre-Marie Duret,
Lionel Spielmann and
Laurrent Messer

Gout Urate Cryst. Depos. Dis.2025, 3(1), 4;https://doi.org/10.3390/gucdd3010004

17 March 2025

This review examines the concept of “psout”, an overlap syndrome of hyperuricemic psoriatic arthritis (HU-PsA) and co-existing gout and PsA. The manuscript explores its epidemiology, pathophysiology, clinical implications, and treatment s...

Full Article

Perspective

5,789 Views

7 Pages

Treat to Target in Gout Management: A Critical Reappraisal of Current Strategies

Anusha Moses,
Martijn Oude Voshaar,
Mart van de Laar and
Tim L. Th. Jansen

Gout Urate Cryst. Depos. Dis.2025, 3(1), 3;https://doi.org/10.3390/gucdd3010003

28 February 2025

Gout management strategies remain a topic of debate, particularly regarding the efficacy of treat-to-target (T2T) and treat-to-avoid-symptoms (T2S) approaches. T2T, endorsed by major rheumatology societies, involves systematic serum urate (sUA) monit...

Full Article

Perspective

2 Citations

5,459 Views

8 Pages

Can Urate Lowering Therapy Be Stopped in Gout? Rationale and Design of Two Large Randomised Trials

Pascal Richette,
Marcel Flendrie,
Leo A. B. Joosten and
Noortje van Herwaarden

Gout Urate Cryst. Depos. Dis.2025, 3(1), 2;https://doi.org/10.3390/gucdd3010002

22 January 2025

Lifelong urate-lowering therapy (ULT) is recommended for gout to prevent flares and urate deposition. However, concerns about its adherence, long-term side effects, and the necessity of continuous treatment after achieving remission raise critical qu...

Full Article

Review

7 Citations

8,347 Views

21 Pages

Gout in China

Aichang Ji,
Zibin Tian,
Yongyong Shi,
Riku Takei,
Shun-Jen Chang,
Ronald M. L. Yip,
Huiyong Yin and
Changgui Li

Gout Urate Cryst. Depos. Dis.2025, 3(1), 1;https://doi.org/10.3390/gucdd3010001

31 December 2024

Gout is a common inflammatory joint disease in China. In recent years, the prevalence of gout in China has been increasing and the onset age of gout has been trending younger. The common risk factors for gout in China include hyperuricemia, age, sex,...

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Gout Urate Cryst. Depos. Dis. - ISSN 2813-4583

Imprint

Download Flyer